News | March 08, 2022
Moderna to set up first mRNA facility in Kenya
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
The revolutionary genetic test helps screen common genes associated with hereditary breast and ovarian cancer in women above 18 years of age
JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
With the implementation of this project, a total of 1,030 acres of cultivable land can be irrigated per crop cycle
Dr. Muffazal Lakdawala performs the largest series of complete robotic gastric bypass surgery in India
Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
Around 85% of ALS patients suffer from a progressive loss of bulbar functionality
Launched in 2020, C-TAP aims to facilitate timely, equitable and affordable access to Covid-19 health products by boosting their production and supply through open, non-exclusive licensing agreements
Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
It plans launch various other health monitoring tools for smartphones, making existing devices obsolete
Subscribe To Our Newsletter & Stay Updated
